Predictors of clinical response: results from a large, randomized controlled study with Tenofovir Disoproxil Fumarate (TDF) plus Peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)

  • STRASSER, S
  • CHAN, H
  • AHN, S
  • CHUANG, W
  • HUI, A
  • TABAK, F
  • MEHTA, R
  • PETERSEN, J
  • LEE, C
  • MA, X
  • CARUNTU, F
  • TAK, W
  • ELKHASHAB, M
  • LIN, L
  • DINH, P
  • MARTINS, E
  • CHARUWORN, P
  • MCHUTCHISON, J
  • SUBRAMANIAN, GM
  • LIM, S
  • FOSTER, G
  • FUNG, S
  • MORANO, L
  • SAMUEL, D
  • AGARWAL, K
  • IDILMAN, R
  • BUTI, M
  • GAETA, G
  • PAPATHEODORIDIS, G
  • FLISIAK, R
  • MARCELLIN, P
Journal of Gastroenterology & Hepatology 30:p 91-92, September 2015.
Copyright © 2015 John Wiley & Sons, Ltd